hantavirus
caus
hantaviru
pulmonari
syndrom
hemorrhag
fever
renal
syndrom
human
enter
cell
hantavirus
fuse
envelop
membran
host
cell
membran
previous
shown
gc
envelop
glycoprotein
viral
fusion
protein
share
characterist
class
ii
fusion
protein
ectodomain
class
ii
fusion
protein
compos
three
domain
connect
stem
region
transmembran
anchor
viral
envelop
fusion
protein
inhibit
exogen
fusion
protein
fragment
span
domain
iii
diii
stem
region
fragment
thought
interact
core
fusion
protein
trimer
transit
prefus
postfus
conform
base
previou
homolog
model
structur
gc
and
hantaviru
andv
predict
gener
recombin
diii
stem
peptid
test
whether
fragment
inhibit
hantaviru
membran
fusion
cell
entri
recombin
andv
diii
solubl
present
disulfid
bridg
betasheet
secondari
structur
support
silico
model
use
diii
ctermin
part
stem
region
infect
cell
andv
block
fusion
andv
occur
within
endosom
rout
fusion
occur
plasma
membran
furthermor
fragment
impair
andv
glycoproteinmedi
cellcel
fusion
crossinhibit
fusion
mediat
glycoprotein
puumala
viru
puuv
gc
fragment
interf
andv
cell
entri
prevent
membran
hemifus
pore
format
retain
gc
nonresist
homotrim
plo
neglect
tropic
diseas
infect
cell
envelop
virus
involv
fusion
membran
virus
cell
process
mediat
viral
fusion
protein
group
least
three
structur
class
membraneenvelop
hantavirus
worldwid
spread
pathogen
caus
human
diseas
mortal
rate
reach
howev
neither
therapeut
drug
prevent
measur
current
avail
show
entranc
and
hantaviru
target
cell
block
fragment
deriv
gc
fusion
protein
analog
inhibitori
fragment
class
ii
fusion
protein
gc
fragment
act
directli
viral
fusion
process
prevent
late
stage
togeth
data
demonstr
hantaviru
gc
protein
share
structur
also
mechanist
similar
class
ii
fusion
protein
suggest
evolut
common
relat
ancestr
fusion
protein
furthermor
result
outlin
novel
approach
therapeut
intervent
stage
describ
diii
stem
peptid
inhibitor
class
ii
fusion
protein
collect
result
demonstr
hantaviru
gc
share
structur
also
mechanist
similar
class
ii
viral
fusion
protein
hope
help
develop
novel
therapeut
strategi
hantavirus
genu
hantaviru
famili
bunyavirida
compris
divers
virus
highli
pathogen
human
asia
europ
hantaan
seoul
puuv
virus
caus
hemorrhag
fever
renal
syndrom
america
andv
sin
nombr
viru
lead
hantaviru
pulmonari
syndrom
mortal
rate
hantavirus
current
lethal
human
pathogen
virus
known
occur
america
due
lack
food
drug
administr
fda
approv
prevent
therapeut
measur
classifi
categori
pathogen
like
member
bunyavirida
famili
hantavirus
triseg
singl
strand
rna
genom
neg
polar
packag
nucleoprotein
viral
ribonucleocapsid
also
associ
viral
rnadepend
rna
polymeras
lipid
membran
envelop
viral
ribonucleocapsid
anchor
viral
gn
gc
glycoprotein
viral
envelop
deriv
host
cell
membran
bud
process
viru
infect
new
cell
hantavirus
bind
cell
surfac
receptor
subsequ
taken
endocytosi
crucial
step
viral
cell
entri
fusion
viru
endosom
membran
host
escap
degrad
lysosom
yet
littl
known
fusion
process
hantavirus
howev
recent
data
show
low
ph
endosom
trigger
nonrevers
fusion
process
gc
protein
insert
target
membran
form
highli
stabl
postfus
homotrim
gener
viruscel
membran
fusion
thought
accomplish
multipl
step
review
activ
viral
fusion
protein
insert
fusion
peptid
fusion
loop
target
membran
intermedi
stage
fusion
peptid
locat
one
end
fusion
protein
opposit
end
anchor
viral
envelop
membran
transmembran
region
therebi
bridg
viral
cellular
membran
undergo
addit
conform
chang
fusion
protein
thought
pull
anchor
togeth
reach
hairpinlik
conform
membraneinsert
domain
locat
end
protein
oppos
membran
brought
close
distanc
introduct
local
membran
curvatur
fusion
outer
leaflet
membran
produc
hemifus
intermedi
follow
full
fusion
membran
fusion
culmin
format
fusion
pore
viru
deliv
ribonucleocapsid
cell
cytosol
initi
replic
viral
fusion
protein
current
group
least
three
differ
class
base
molecular
structur
class
fusion
protein
high
alpha
helic
content
class
ii
protein
consist
princip
beta
sheet
class
iii
fusion
protein
includ
characterist
first
two
class
review
earli
silico
vitro
analys
suggest
gc
glycoprotein
hantavirus
share
structur
similar
class
ii
fusion
protein
notion
also
propos
member
bunyavirida
crystal
structur
gc
rift
valley
fever
viru
rvfv
ultim
confirm
notion
phlebovirus
class
ii
fusion
protein
compos
three
domain
iiii
stem
region
connect
ectodomain
transmembran
anchor
adopt
hairpinlik
structur
diii
move
toward
fusion
loop
stem
region
connect
transmembran
anchor
thought
follow
movement
diii
fold
trimer
core
form
fusion
protein
extens
conform
chang
occur
fusion
process
offer
opportun
disrupt
fusion
cascad
therebi
block
viral
infect
ligand
bind
select
intermedi
form
fusion
protein
preced
postfus
conform
delay
inhibit
viral
entri
case
human
immunodefici
viru
fusion
protein
class
fold
licens
drug
base
peptid
review
peptid
compris
partial
sequenc
outer
layer
trimer
postfus
hairpin
conform
bind
trimer
core
fusion
protein
extend
intermedi
conform
prevent
foldback
reaction
review
among
class
ii
protein
diii
stem
region
form
outer
layer
trimer
postfus
conform
liao
kielian
show
addit
solubl
diii
without
stem
region
semliki
forest
viru
protein
solubl
diii
dengu
viru
type
e
protein
inhibit
entri
respect
viru
cell
confirm
common
inhibitori
mechan
class
class
ii
fusion
protein
studi
shown
peptid
deriv
stem
region
fusion
protein
flaviand
phlebovirus
also
inhibit
viral
cell
entri
bind
stem
peptid
fusion
protein
thought
prevent
postfus
conform
case
diii
howev
amphipath
characterist
seem
allow
bind
viru
attach
cell
henc
thought
carri
viru
endosom
characterist
provid
advantag
deliveri
inhibitor
site
viruscel
membran
fusion
process
occur
close
endosom
compart
hypothes
hantaviru
gc
share
mechanist
similar
class
ii
fusion
protein
inhibit
strategi
use
class
ii
fusion
protein
test
hypothesi
predict
produc
diii
stem
region
andv
gc
assess
andv
inhibit
result
show
inde
recombin
diii
synthet
stem
peptid
interf
andv
infect
act
late
stage
andv
fusion
process
pcr
amplif
predict
diii
diii
sequenc
use
clone
cdna
segment
andv
isol
puuv
strain
clone
pwrgpuuvm
express
plasmid
kindli
provid
jay
hooper
usamriid
usa
genbank
access
number
respect
pcr
product
clone
gave
rise
fusion
protein
ntermin
tag
residu
includ
polyhistidin
histag
prepar
diii
without
histag
pcr
product
andv
diii
clone
express
product
plasmid
contain
ntermin
tag
residu
includ
glutathion
transferas
gst
affin
tag
follow
cleavag
site
tobacco
etch
viru
tev
proteas
cleavag
tev
proteas
residu
gstfusion
protein
remain
fuse
ntermin
diii
correspond
sequenc
gamdpef
express
recombin
diii
protein
perform
establish
brief
histag
fusion
protein
express
escherichia
coli
ecoli
transform
differ
plasmid
isopropylbetadthiogalactopyranosideinduc
bacteria
lyse
sonic
buffer
contain
mm
tri
mm
nacl
mm
phenylmethanesulfonylfluorid
ph
lysi
perform
sonic
ice
solubl
protein
purifi
ion
exchang
resin
biorex
biorad
laboratori
follow
tandem
ultrafiltr
devic
kda
kda
molecular
weight
cutoff
recombin
untag
diii
produc
follow
similar
purif
procedur
describ
elsewher
modif
briefli
e
coli
origami
novagen
transform
express
induc
bacteria
pellet
lyse
describ
clarifi
supernat
purifi
glutathionesepharos
ge
healthcar
bound
protein
elut
mm
reduc
glutathion
sigmaaldrich
tev
proteas
use
cleav
gst
moieti
gst
moieti
tev
proteas
remov
sequenti
passag
glutathionesepharos
ninta
qiagen
resin
eventu
diii
concentr
use
ultrafiltr
devic
kda
cutoff
purifi
hiload
superdex
prep
grade
column
ge
healthcar
protein
analyz
standard
trisglycin
sdspolyacrylamid
gel
electrophoresi
use
gel
irrevers
reduct
mm
dithiothreitol
ad
protein
heat
min
subsequ
alkyl
incub
mm
iodoacetamid
min
circular
dichroism
measur
perform
use
spectropolarimet
scan
record
room
temperatur
nm
use
mm
optic
pass
cuvett
measur
valu
ellipt
convert
ellipt
per
amino
acid
residu
deconvolut
spectra
differ
databas
contin
cdsstr
server
use
peptid
span
predict
stem
region
andv
gc
synthes
new
england
peptid
ntermin
peptid
compris
sequenc
hlervtgfnqidsdkvydd
gapp
ctermin
peptid
compris
sequenc
tfkcwftksgewllgiln
gn
two
addit
peptid
use
compris
either
first
ten
residu
last
ten
residu
peptid
respect
avoid
introduct
addit
charg
ctermin
amidemodifi
ntermin
acidmodifi
compris
sequenc
tfkcwftksg
ewllgilngn
respect
nn
peptid
compris
sequenc
qlvtarqklkdaekavevdpddvnkstlqrraav
stletklg
deriv
andv
nucleoprotein
use
control
nucleoproteinbas
peptid
chosen
limit
possibl
interor
intramolecular
interact
fusion
protein
may
occur
conform
chang
fusion
process
nn
peptid
residu
use
control
short
r
peptid
longer
diii
fragment
peptid
solubl
hne
buffer
mm
hepe
mm
nacl
mm
edta
ph
except
peptid
dissolv
mm
borat
buffer
ph
andv
isol
kindli
provid
galeno
instituto
de
salud
chile
propag
vero
cell
attc
describ
work
involv
infecti
viru
perform
biosafeti
level
condit
centro
de
investigacion
pontificia
universidad
de
chile
chile
cell
invitrogen
propag
dmem
supplement
fetal
calf
serum
fc
cell
attc
grown
medium
contain
fc
infect
vero
cell
andv
multipl
infect
moi
quantifi
flow
cytometri
formerli
establish
briefli
cell
incub
andv
h
presenc
absenc
protein
peptid
inhibitor
candid
subsequ
cell
wash
infect
allow
proceed
h
cell
next
fix
wv
paraformaldehyd
viru
inactiv
permeabil
triton
immunofluoresc
stain
cell
incub
min
antiandv
n
monoclon
antibodi
mab
primari
antibodi
detect
goat
antimous
immunoglobulin
conjug
alexa
life
technolog
cell
condit
analyz
use
flow
cytomet
fac
ii
becton
dickinson
standard
deviat
least
n
experi
indic
error
bar
valu
product
simian
immunodefici
viru
siv
vector
pseudotyp
vesicular
stomat
viru
vsv
g
protein
andv
glycoprotein
transduct
siv
vector
bear
vsv
glycoprotein
prepar
indic
elsewher
briefli
cell
transfect
plasmid
code
siv
gagpol
plasmid
encod
gfp
rna
minigenom
plasmid
code
envelop
protein
g
vsv
pvsvg
clontech
altern
plasmid
code
andv
glycoprotein
use
gener
siv
vector
pseudotyp
andv
glycoprotein
h
posttransfect
supernat
contain
pseudotyp
particl
concentr
centrifug
g
min
differ
dilut
vsvg
pseudotyp
siv
vector
incub
h
vero
cell
presenc
absenc
protein
peptid
inhibitor
candid
three
day
later
express
gfp
transduc
cell
analyz
flow
cytometri
facscan
becton
dickinson
cell
count
experiment
condit
cell
prolifer
assay
use
assess
cytotox
gc
domain
peptid
describ
manufactur
promega
briefli
gc
domain
peptid
incub
vero
cell
h
convers
tetrazolium
formazan
assess
measur
absorb
nm
micropl
reader
synergi
biotek
threecolor
base
cellcel
fusion
assay
perform
establish
briefli
h
transfect
vero
cell
pwrgpuuvm
code
glycoprotein
andv
puuv
respect
cell
incub
low
ph
media
emem
mm
sodium
succin
ph
min
three
hour
later
cell
cytoplasm
stain
diacet
celltrack
green
cmfda
invitrogen
cell
nuclei
dapi
life
technolog
gc
label
antigc
mab
antimous
immunoglobulin
conjug
invitrogen
fusion
index
gcexpress
cell
calcul
formula
sampl
approxim
nuclei
per
field
count
magnif
mean
fusion
index
five
field
calcul
n
vero
cell
prechil
ice
min
mm
nh
cl
adsorpt
andv
moi
perform
next
cell
wash
fusion
viru
plasma
membran
trigger
incub
low
ph
media
emem
mm
sodium
succin
ph
min
presenc
absenc
inhibitor
candid
next
cell
wash
infect
follow
incub
h
presenc
mm
nh
cl
subsequ
viral
infect
assess
describ
multimer
state
gc
assess
sucros
gradient
centrifug
previous
establish
briefli
andv
treat
ph
allow
rearrang
glycoprotein
viral
envelop
indic
diii
ad
viru
low
ph
incub
min
subsequ
viral
glycoprotein
extract
triton
separ
gradient
wv
sucros
centrifug
g
h
fraction
collect
presenc
gc
fraction
assess
western
blot
analysi
use
antigc
mab
molecular
mass
fraction
assess
coomassi
stain
molecular
marker
gel
filtrat
standard
biorad
appli
sediment
gradient
experiment
molecular
mass
marker
next
plot
log
theoret
molecular
mass
panel
western
blot
gradient
stabil
gc
homotrim
test
trypsin
digest
indic
briefli
wellcharacter
vlp
project
andv
glycoprotein
prepar
describ
elsewher
incub
min
ph
acidif
vlp
incub
tcpk
trypsin
sigma
indic
time
final
digest
stop
ad
sampl
buffer
heat
min
digest
gc
test
western
blot
analysi
use
antigc
mab
describ
assay
transfer
monosialotetrahexosylgangliosid
effector
cell
target
cell
measur
describ
snare
protein
adapt
assay
measur
andv
glycoproteinmedi
transfer
cell
transfect
use
lipofectamin
invitrogen
indic
manufactur
fortyf
h
posttransfect
cell
detach
plate
resuspend
supplement
dmem
time
target
cell
trypsin
label
celltrack
blue
cmac
invitrogen
supplement
medium
min
excess
dye
remov
replac
dyecontain
media
supplement
medium
subsequ
incub
min
wash
pb
target
cell
resuspend
supplement
dmem
next
effector
cell
transfect
cell
cmaclabel
target
cell
cell
combin
ratio
effector
target
h
fusion
protein
activ
incub
cell
low
ph
media
dmem
sodium
succin
mm
fc
ph
min
medium
replac
supplement
dmem
ph
min
incub
cell
fix
paraformaldehyd
fluoresc
stain
cell
incub
min
cholera
toxin
ctx
conjug
alexa
fluor
invitrogen
wash
pb
mount
dabco
cell
examin
confoc
microscopi
fluorview
olympu
singl
plane
imag
differ
microscop
field
taken
condit
percentag
transfer
calcul
use
formula
n
correspond
number
cell
posit
cmac
n
b
correspond
number
cell
posit
furthermor
contact
least
one
target
cell
cell
consid
posit
transfer
fluoresc
label
detect
full
circumfer
cell
standard
deviat
least
n
experi
calcul
indic
error
bar
valu
ttest
perform
statist
evalu
n
independ
epxeri
p
p
p
hantaviru
gc
protein
predict
diii
stem
region
sequenc
align
known
class
ii
fusion
protein
subsequ
model
deriv
protein
includ
among
other
recent
crystal
rvfv
gc
none
new
sequenc
align
achiev
higher
sequenc
ident
greater
cystein
match
model
valid
score
compar
align
use
origin
gc
model
structur
base
prefus
structur
tickborn
enceph
viru
tbev
e
protein
pdbid
reason
use
align
origin
andv
gc
model
identifi
put
diii
andv
gc
fig
sequenc
deriv
model
residu
term
andv
diii
serv
templat
predict
put
diii
gc
hantavirus
puuv
subsequ
defin
put
stem
region
andv
gc
sequenc
encompass
residu
correspond
region
ctermin
end
predict
diii
predict
gc
transmembran
region
obtain
tmpred
server
fig
product
diii
differ
class
ii
fusion
protein
includ
flavivirus
alphavirus
previous
establish
e
coli
feasibl
prepar
solubl
diii
flaviand
alphavirus
prokaryot
express
system
retain
nativ
structur
may
relat
globular
igglik
fold
lack
glycosyl
purif
diii
gener
achiev
inclus
bodi
follow
refold
supernat
cell
lysat
prepar
three
recombin
diii
protein
diii
deriv
andv
gc
without
ntermin
histag
andv
hdiii
andv
diii
diii
puuv
gc
ntermin
histag
puuv
hdiii
protein
obtain
supernat
e
coli
origami
cell
elut
purif
singl
peak
detect
absorb
nm
fig
show
elut
profil
exampl
purifi
andv
diii
last
size
exclus
chromatographi
column
togeth
homogen
prepar
assess
sdspage
predict
andv
puuv
diii
sequenc
contain
eight
highli
conserv
cystein
residu
diii
protein
next
character
presenc
disulfid
bridg
reduct
subsequ
alkyl
increas
electrophoret
mobil
could
detect
reduc
andv
diii
andv
hdiii
puuv
hdiii
compar
unreduc
control
fig
indic
cystein
seem
arrang
disulfid
bridg
next
explor
presenc
secondari
structur
element
diii
hantavirus
circular
dichroism
spectra
show
uniqu
neg
maximum
nm
fig
confirm
presenc
secondari
structur
deconvolut
circular
dichroism
spectra
four
compon
differ
server
indic
diii
contain
random
coil
turn
content
close
zero
composit
coincid
high
content
turn
observ
diii
class
ii
fusion
protein
take
data
togeth
monomer
form
recombin
andv
diii
solut
presenc
disulfid
bridg
secondari
structur
content
solubl
recombin
protein
mgml
indic
diii
fold
addit
also
produc
protein
span
predict
diii
stem
region
andv
gc
includ
ntermin
histag
andv
hdiii
howev
obtain
enough
andv
hdiii
purif
presum
due
poor
solubl
protein
overcom
difficulti
gener
predict
gc
stem
region
separ
two
synthet
peptid
one
span
ntermin
part
peptid
span
ctermin
part
peptid
fig
also
use
neg
control
peptid
compris
region
andv
nucleoprotein
nn
peptid
predict
diii
stem
fragment
synthes
purifi
character
measur
inhibitori
activ
andv
viru
cell
entri
via
nativ
endosom
infect
rout
purpos
andv
incub
vero
cell
presenc
gc
fragment
h
incub
cell
wash
infect
monitor
h
base
earlier
establish
protocol
andv
diii
andv
hdiii
reduc
andv
infect
fig
ntermin
histag
improv
inhibit
viral
infect
observ
alphaand
flaviviru
diii
protein
interestingli
puuv
hdiii
show
crossinhibit
andv
result
unexpect
sinc
crossreact
diii
report
within
alphaviru
flaviviru
genera
like
absenc
crossinhibit
due
presenc
ntermin
histag
puuv
diii
see
result
fig
next
test
whether
andv
stem
peptid
also
impair
andv
infect
peptid
compris
ctermin
part
predict
gc
stem
region
block
infect
cell
andv
fig
contrast
peptid
span
ntermin
part
predict
gc
stem
show
reduct
andv
infect
similar
neg
control
nn
peptid
fig
test
whether
specif
region
requir
inhibit
test
two
differ
part
see
fig
ntermin
ctermin
peptid
show
similar
reduc
effect
viral
infect
fig
explor
specif
gc
fragment
viral
inhibit
use
model
unrel
vesicular
stomat
viru
vsv
vsv
enter
cell
endocytosi
low
phtrigger
fusion
viru
achiev
fusion
differ
class
fusion
protein
class
iii
analyz
vsvmediat
entri
siv
vector
pseudotyp
envelop
glycoprotein
g
vsv
transduct
cell
vector
evalu
express
gfp
report
gene
neither
andv
diii
andv
stem
peptid
alter
cell
transduct
test
concentr
respect
fig
contrast
ph
endocyt
rout
neutral
weak
base
ammonium
chlorid
vsvg
mediat
transduct
block
fig
hand
siv
vector
pseudotyp
andv
glycoprotein
diii
fragment
inhibit
vector
respect
fig
corrobor
inhibitori
fragment
activ
system
none
gcderiv
peptid
recombin
domain
abrog
viabil
cell
incub
vero
cell
fig
indic
reduct
andv
infect
due
cytopath
effect
gcderiv
fragment
previous
report
flaviviru
stem
peptid
bind
viru
enter
cell
help
deliveri
endosom
compart
base
observ
compar
inhibit
andv
preincub
viru
peptid
b
coincub
peptid
viru
adsorpt
cell
compar
result
experiment
design
similar
dosedepend
inhibit
could
observ
fig
coincid
result
obtain
flavivirus
base
result
seem
plausibl
bind
peptid
andv
may
occur
fast
make
longer
incub
time
unnecessari
taken
togeth
data
demonstr
exogen
fragment
deriv
andv
gc
compris
predict
diii
ctermin
part
predict
stem
region
abrog
entri
andv
cell
inhibitori
potenti
gc
fragment
next
test
cellcel
fusion
assay
driven
andv
glycoprotein
therefor
transfect
vero
cell
plasmid
presenc
exogen
diii
stem
peptid
transduct
assess
gfp
report
gene
express
use
flow
cytometri
transduct
defin
transduct
absenc
gcderiv
fragment
mock
e
cytotox
analysi
gc
diii
protein
stem
peptid
vero
cell
f
andv
inhibit
stem
peptid
preincub
coincub
preincub
andv
code
andv
glycoprotein
incub
cell
h
posttransfect
low
ph
media
min
describ
materi
method
acidif
media
allow
activ
viral
gc
fusion
protein
plasma
membran
cell
therebi
trigger
format
syncytia
andv
gc
fragment
incorpor
low
ph
incub
step
andv
diii
andv
hdiii
diminish
glycoproteinmedi
fusion
activ
respect
fig
concord
result
obtain
infecti
andv
fig
puuv
hdiii
achiev
crossinhibit
andv
glycoprotein
fig
hand
andv
stem
peptid
impair
andv
glycoprotein
fusion
activ
fig
andvderiv
gc
fragment
likewis
test
potenti
crossinhibit
hantavirus
puuv
therefor
perform
cellcel
fusion
assay
driven
puuv
glycoprotein
assay
puuv
hdiii
block
puuv
glycoproteinmedi
fusion
process
reduc
fusion
fig
result
coincid
concentr
rang
andv
diii
protein
block
andv
glycoprotein
fusion
activ
confirm
activ
puuv
hdiii
test
andv
diii
protein
crossinhibit
found
andv
diii
andv
hdiii
block
puuv
glycoproteinmedi
fusion
fig
result
togeth
data
absent
crossreact
puuv
hdiii
andv
suggest
hantaviru
diii
protein
without
ntermin
histag
crossinhibit
activ
howev
ntermin
histag
domain
seem
interfer
inhibit
thu
far
notion
remain
corrobor
puuv
diii
lack
ntermin
histag
test
andv
stem
peptid
block
puuvmedi
fusion
found
also
crossinhibit
function
fig
among
peptid
reach
highest
crossreduct
result
line
observ
peptid
also
achiev
highest
inhibit
valu
andvmedi
cellcel
fusion
collect
result
hantaviru
crossinhibit
suggest
residu
diii
stem
fragment
involv
intramolecular
interact
residu
seem
conserv
andv
puuv
fig
allow
crossinteract
exogen
diii
stem
fragment
differ
hantaviru
andv
cell
entri
block
differ
step
receptor
bind
membran
fusion
hantavirus
envelop
glycoprotein
specif
domain
involv
bind
receptor
yet
identifi
discard
possibl
effect
andv
inhibitor
step
preced
viruscel
membran
fusion
incub
cell
andv
diii
peptid
h
addit
viru
unbound
fragment
subsequ
wash
cell
infect
andv
addit
neither
diii
respect
cell
incub
andv
led
signific
decreas
viru
infect
fig
data
emphas
preincub
diii
stem
fragment
abrog
earli
step
viru
infect
receptor
bind
cellular
signal
pathway
furthermor
result
coincid
data
obtain
stem
peptid
deriv
preincub
cell
peptid
also
affect
infect
next
ask
whether
diii
stem
fragment
interf
directli
viruscel
fusion
process
test
assess
inhibit
fusion
infect
assay
fuse
andv
plasma
membran
therefor
andv
prebound
cell
andv
diii
ad
min
low
ph
puls
trigger
fusion
blockad
viral
entri
pathway
highli
effici
case
peptid
reach
inhibit
fig
recombin
diii
led
lower
inhibit
effici
result
comparison
obtain
could
explain
short
incub
time
experiment
design
compar
inhibit
normal
entri
rout
viru
higher
concentr
andv
diii
might
necessari
inhibit
sinc
input
viru
use
reach
similar
level
infect
moi
take
data
togeth
result
confirm
exogen
diii
stem
fragment
function
specif
viral
fusion
process
sinc
fusion
process
involv
multipl
step
next
assess
specif
stage
gc
fragment
interfer
process
end
start
analyz
trimer
gc
use
earlier
protocol
andv
therefor
incub
neutral
low
ph
without
diii
subsequ
viral
glycoprotein
extract
viru
appli
sucros
gradient
evalu
molecular
mass
ultracentrifug
fraction
examin
western
blot
analysi
presenc
gc
gradient
sediment
ph
led
detect
gc
fraction
correspond
molecular
mass
gc
monom
kda
fraction
presenc
absenc
andv
diii
fig
two
gc
migrat
band
could
observ
reduc
electrophoret
system
may
correspond
differ
oxid
form
gc
describ
earlier
lower
molecular
mass
band
previous
found
shift
gc
monom
neutral
ph
gc
trimer
low
ph
incub
andv
ph
presenc
absenc
diii
inhibitor
lower
molecular
mass
band
gc
shift
fraction
correspond
monom
found
fraction
correspond
gc
homotrim
fraction
fig
result
indic
andv
diii
abrog
neither
gc
fusion
activ
gc
trimer
postfus
conform
andv
gc
correspond
highli
stabl
homotrim
context
next
explor
stabil
gc
homotrim
form
presenc
exogen
diii
stem
fragment
assess
resist
proteas
digest
experiment
approach
use
andvlik
particl
vlp
sinc
purifi
higher
concentr
viru
vlp
resembl
viral
envelop
expos
gn
gc
glycoprotein
test
trypsin
resist
vlp
first
incub
neutral
low
ph
presenc
absenc
inhibitor
subsequ
subject
digest
trypsin
differ
incub
time
expect
neutral
ph
form
gc
fulli
degrad
within
min
low
ph
form
gc
larg
resist
digest
fig
contrast
gc
lost
trypsin
resist
digest
could
observ
andv
diii
peptid
coincub
vlp
low
ph
incub
step
indic
interf
format
stabl
gc
homotrim
fig
residu
gc
could
detect
like
diii
stem
fragment
block
gc
molecul
coincid
inhibitori
result
fig
format
stabl
homotrim
howev
prevent
control
peptid
nn
ad
acidif
either
nn
peptid
diii
peptid
ad
low
ph
incub
confirm
specif
assay
togeth
data
suggest
exogen
diii
stem
fragment
prevent
format
stabl
postfus
hairpin
structur
presum
direct
bind
gc
extend
intermedi
conform
presenc
exogen
gc
fragment
interf
neither
activ
andv
gc
homotrimer
howev
allow
format
stabl
postfus
structur
hemifus
intermedi
stage
occur
fusion
step
outer
membran
viru
cell
fuse
inner
leaflet
still
remain
apart
order
test
inhibit
andv
exogen
diii
occur
hemifus
intermedi
state
develop
hemifus
assay
andv
glycoprotein
purpos
took
advantag
previous
develop
cellcel
fusion
assay
cell
express
andv
glycoprotein
effector
cell
cell
target
cell
assay
low
phtrigger
transfer
effector
cell
target
cell
analyz
confoc
microscopi
allow
detect
cell
surfac
singl
focal
plane
minim
sampl
intervent
fig
allow
unambigu
identif
transfer
effector
cell
target
cell
cell
defin
label
detect
full
circumfer
fig
red
arrow
convers
target
cell
contact
effector
cell
show
partial
stain
defin
fig
yellow
arrow
although
assay
allow
detect
lipid
mix
cell
discrimin
full
fusion
hemifus
membran
obtain
quantit
measur
transfer
effector
target
cell
quantifi
percentag
transfer
condit
ph
background
level
transfer
around
observ
condit
fig
glycoprotein
activ
ph
effector
cell
target
cell
detect
mock
control
treatment
fig
howev
andv
diii
incorpor
low
ph
incub
transfer
appear
less
frequent
decreas
fig
valu
still
higher
background
level
observ
transfer
neutral
ph
indic
domain
reduc
lipid
mix
incomplet
manner
probabl
exogen
andv
diii
make
contact
fusion
protein
short
low
ph
incub
coincid
result
block
cellcel
fusion
see
fig
impair
highli
specif
sinc
incorpor
puuv
hdiii
crossinhibit
activ
andv
see
fig
abrog
acidinduc
transfer
fig
summari
result
show
andv
diii
arrest
fusion
process
gc
trimer
reach
hemifus
intermedi
context
seem
like
gc
fragment
prevent
movement
endogen
diii
stem
region
toward
core
gc
trimer
describ
class
ii
fusion
protein
fusion
viral
membran
host
cell
membran
crucial
step
entri
envelop
virus
cell
present
studi
demonstr
predict
diii
stem
fragment
block
acidinduc
fusion
andv
within
endosom
entri
pathway
cell
surfac
fusion
allow
proceed
gc
trimer
prevent
membran
hemifus
fusion
pore
format
result
provid
novel
inform
inhibitori
strategi
andv
hantavirus
also
provid
proof
concept
gc
share
structur
similar
overal
fold
class
ii
fusion
protein
compar
inhibit
hantavirus
exogen
diii
class
ii
fusion
protein
andv
puuv
hantavirus
block
andv
diii
without
addit
ntermin
histag
ctermin
residu
although
contain
seven
ntermin
residu
deriv
gsttag
addit
ntermin
histag
achiev
improv
block
fusion
semliki
forest
viru
andv
diii
without
ntermin
histag
achiev
similar
inhibitori
result
sfv
diii
propos
ntermin
tag
may
mimic
domain
idiii
linker
region
therebi
stabil
interact
fusion
protein
core
hand
report
presenc
ctermin
residu
deriv
stem
region
necessari
inhibit
exogen
diii
chikungunya
viru
e
protein
specif
chikungunya
viru
shown
nine
residu
e
stem
region
requir
diii
bind
fusion
protein
domain
idomain
ii
core
henc
potenc
inhibit
andv
fusion
process
andv
puuv
diii
may
improv
futur
studi
ad
ctermin
residu
andv
diii
includ
stem
region
larg
insolubl
therefor
larger
gc
fragment
could
test
andv
entri
assay
peptid
span
first
ntermin
residu
stem
region
affect
andv
entri
peptid
span
last
ctermin
residu
block
andv
infect
similar
extent
diii
test
two
peptid
compris
either
ctermin
half
andv
stem
peptid
inhibitori
activ
andv
larg
retain
peptid
henc
peptid
seem
contain
residu
two
region
particip
similarli
inhibit
similar
ctermin
region
andv
stem
region
ctermin
region
ntermin
e
protein
bind
block
fusion
protein
interestingli
inhibitori
peptid
deriv
membran
proxim
region
stem
region
divers
fusion
protein
rvfv
sarscoronaviru
influenza
viru
hepat
c
viru
found
like
interact
membran
interfac
hydropathi
segment
predict
wimleywhit
interfaci
hydrophob
scale
wwih
transfer
peptid
aqueou
environ
palmitoyloleoylphosphatidyl
cholin
interfac
need
membranebind
properti
inhibitori
activ
coincid
studi
peptid
deriv
stem
region
alphaviru
fusion
protein
peptid
gener
wwih
valu
tabl
indic
weak
membran
bind
fail
block
alphaviru
fusion
activ
case
e
protein
membranebind
sequenc
found
ctermin
end
peptid
high
wwih
valu
tabl
fact
stem
peptid
e
protein
shown
interfer
fusion
viru
endosom
compart
twostep
mechan
first
bind
viral
membran
outsid
cell
next
bind
e
core
trimer
fusion
trigger
endocyt
compart
use
wimleywhit
scale
interfaci
hydropathi
segment
wwih
vale
predict
andv
gc
stem
region
coincid
sequenc
peptid
tabl
indic
moder
membran
partit
andv
peptid
would
interact
membran
hydropathi
segment
interact
favor
andv
inhibit
suffici
endosom
rout
sinc
fusion
impair
effici
directli
present
fusion
compart
appli
concentr
stem
peptid
block
andv
infect
entri
occur
via
endocyt
pathway
reach
inhibit
andv
infect
fusion
occur
plasma
membran
sens
modif
peptid
favor
membran
interact
introduc
peptid
deriv
west
nile
viru
e
stem
region
membran
proxim
region
influenza
viru
hemagglutinin
hiv
may
help
futur
improv
inhibitori
activ
direct
toward
close
environ
endosom
andv
diii
stem
peptid
block
fusion
mediat
andv
glycoprotein
also
fusion
activ
glycoprotein
anoth
hantaviru
puuv
result
accord
high
sequenc
ident
diii
virus
also
report
crossinhibit
activ
diii
within
genu
alphaviru
diii
conserv
high
howev
ntermin
histag
andv
hdiii
seem
prevent
crossinhibit
puuv
fusion
activ
indic
tag
may
interfer
specif
bind
gc
heterolog
speci
like
histidin
tag
becom
posit
charg
low
ph
environ
turn
may
induc
repuls
posit
charg
residu
gc
hantavirus
repuls
may
overcom
higher
bind
affin
diii
gc
hantaviru
heterolog
virus
addit
diii
andv
peptid
deriv
stem
region
andv
also
crossinhibit
puuv
fusion
activ
corrobor
presenc
conserv
residu
among
hantaviru
gc
protein
involv
like
bind
peptid
crossinhibit
fusion
protein
stem
peptid
previous
report
virus
genu
flaviviru
dengu
viru
stem
peptid
block
differ
dengu
viru
serotyp
flavivirus
absenc
crossinhibit
case
relat
poor
interact
respect
e
protein
rather
poor
interact
viral
membran
final
stem
peptid
deriv
rvfv
gc
protein
report
block
three
differ
class
viral
fusion
protein
act
broadspectrum
fusion
inhibitor
exogen
stem
peptid
andv
observ
crossinhibit
fusion
protein
vsv
concentr
therefor
like
andv
stem
fragment
may
appli
inhibit
similar
virus
within
genu
viral
fusion
machineri
taken
whole
result
demonstr
strategi
employ
class
ii
fusion
protein
allow
inhibit
hantavirus
andv
puuv
although
target
endosom
site
viru
fusion
yet
optim
possibl
block
fusion
infect
physiolog
viru
entri
condit
hope
novel
inhibitori
strategi
base
andv
diii
stem
peptid
help
futur
develop
therapeut
strategi
differ
hantavirus
support
inform
tabl
predict
hydropathi
segment
